Terms: = Prostate cancer AND CEBPA, CEBP, 1050, C/EBP-alpha, P49715 AND Prognosis
3 results:
1. Cyclin D1 and PSA act as good prognostic and clinicopathological indicators for breast cancer.
Holah NS; Hemida AS
J Immunoassay Immunochem; 2020; 41(1):28-44. PubMed ID: 31631753
[TBL] [Abstract] [Full Text] [Related]
2. Loss of CCAAT-enhancer-binding protein alpha (cebpa) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers.
Minner S; Lutz J; Hube-Magg C; Kluth M; Simon R; Höflmayer D; Burandt E; Tsourlakis MC; Sauter G; Büscheck F; Wilczak W; Steurer S; Schlomm T; Huland H; Graefen M; Haese A; Heinzer H; Jacobsen F; Hinsch A; Poos A; Oswald M; Rippe K; König R; Schroeder C
Prostate; 2019 Feb; 79(3):302-311. PubMed ID: 30430607
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic significance of patterns of seminal vesicle invasion in prostate cancer.
Kristiansen A; Wiklund F; Wiklund P; Egevad L
Histopathology; 2013 Jun; 62(7):1049-56. PubMed ID: 23570376
[TBL] [Abstract] [Full Text] [Related]
